125 related articles for article (PubMed ID: 35674867)
41. Synergistic effects of docetaxel and S-1 by modulating the expression of metabolic enzymes of 5-fluorouracil in human gastric cancer cell lines.
Wada Y; Yoshida K; Suzuki T; Mizuiri H; Konishi K; Ukon K; Tanabe K; Sakata Y; Fukushima M
Int J Cancer; 2006 Aug; 119(4):783-91. PubMed ID: 16557585
[TBL] [Abstract][Full Text] [Related]
42. MEL-pep, an analog of melittin, disrupts cell membranes and reverses 5-fluorouracil resistance in human hepatocellular carcinoma cells.
Ke M; Dong J; Wang Y; Zhang J; Zhang M; Wu Z; Lv Y; Wu R
Int J Biochem Cell Biol; 2018 Aug; 101():39-48. PubMed ID: 29800725
[TBL] [Abstract][Full Text] [Related]
43. Relationships between the expression of thymidylate synthase, dihydropyrimidine dehydrogenase, and orotate phosphoribosyltransferase and cell proliferative activity and 5-fluorouracil sensitivity in colorectal carcinoma.
Fujii R; Seshimo A; Kameoka S
Int J Clin Oncol; 2003 Apr; 8(2):72-8. PubMed ID: 12720098
[TBL] [Abstract][Full Text] [Related]
44. MiR-27a modulates the MDR1/P-glycoprotein expression by inhibiting FZD7/β-catenin pathway in hepatocellular carcinoma cells.
Chen Z; Ma T; Huang C; Zhang L; Lv X; Xu T; Hu T; Li J
Cell Signal; 2013 Dec; 25(12):2693-701. PubMed ID: 24018051
[TBL] [Abstract][Full Text] [Related]
45. HPLC assay of uridine monophosphate synthase (UMPS) in chorionic villus samples (CVS) and erythrocytes (RBC).
Fairbanks LD; Duley JA; Shores AJ; Simmonds HA
Adv Exp Med Biol; 1991; 309B():35-8. PubMed ID: 1781395
[No Abstract] [Full Text] [Related]
46. MiR-141 Activates Nrf2-Dependent Antioxidant Pathway via Down-Regulating the Expression of Keap1 Conferring the Resistance of Hepatocellular Carcinoma Cells to 5-Fluorouracil.
Shi L; Wu L; Chen Z; Yang J; Chen X; Yu F; Zheng F; Lin X
Cell Physiol Biochem; 2015; 35(6):2333-48. PubMed ID: 25896253
[TBL] [Abstract][Full Text] [Related]
47. Pharmacokinetic and Pharmacodynamic Factors Contribute to Synergism between Let-7c-5p and 5-Fluorouracil in Inhibiting Hepatocellular Carcinoma Cell Viability.
Jilek JL; Tu MJ; Zhang C; Yu AM
Drug Metab Dispos; 2020 Dec; 48(12):1257-1263. PubMed ID: 33051247
[TBL] [Abstract][Full Text] [Related]
48. Vitamin K2 augments 5-fluorouracil-induced growth inhibition of human hepatocellular carcinoma cells by inhibiting NF-κB activation.
Zhang H; Ozaki I; Hamajima H; Iwane S; Takahashi H; Kawaguchi Y; Eguchi Y; Yamamoto K; Mizuta T
Oncol Rep; 2011 Jan; 25(1):159-66. PubMed ID: 21109972
[TBL] [Abstract][Full Text] [Related]
49. Six2 is negatively correlated with good prognosis and decreases 5-FU sensitivity via suppressing E-cadherin expression in hepatocellular carcinoma cells.
Li JW; Huang CZ; Li JH; Yuan JH; Chen QH; Zhang WF; Xu ZS; Liu YP; Li Y; Zhan MX; Lu LG
Biomed Pharmacother; 2018 Aug; 104():204-210. PubMed ID: 29772441
[TBL] [Abstract][Full Text] [Related]
50. Rosiglitazone sensitizes hepatocellular carcinoma cell lines to 5-fluorouracil antitumor activity through activation of the PPARgamma signaling pathway.
Cao LQ; Wang XL; Wang Q; Xue P; Jiao XY; Peng HP; Lu HW; Zheng Q; Chen XL; Huang XH; Fu XH; Chen JS
Acta Pharmacol Sin; 2009 Sep; 30(9):1316-22. PubMed ID: 19684609
[TBL] [Abstract][Full Text] [Related]
51. Histone deacetylase inhibitors sensitize 5-fluorouracil-resistant MDA-MB-468 breast cancer cells to 5-fluorouracil.
Minegaki T; Suzuki A; Mori M; Tsuji S; Yamamoto S; Watanabe A; Tsuzuki T; Tsunoda T; Yamamoto A; Tsujimoto M; Nishiguchi K
Oncol Lett; 2018 Nov; 16(5):6202-6208. PubMed ID: 30333885
[TBL] [Abstract][Full Text] [Related]
52. miRNA-195 sensitizes human hepatocellular carcinoma cells to 5-FU by targeting BCL-w.
Yang X; Yin J; Yu J; Xiang Q; Liu Y; Tang S; Liao D; Zhu B; Zu X; Tang H; Lei X
Oncol Rep; 2012 Jan; 27(1):250-7. PubMed ID: 21947305
[TBL] [Abstract][Full Text] [Related]
53. Decreased levels of UMP kinase as a mechanism of fluoropyrimidine resistance.
Humeniuk R; Menon LG; Mishra PJ; Gorlick R; Sowers R; Rode W; Pizzorno G; Cheng YC; Kemeny N; Bertino JR; Banerjee D
Mol Cancer Ther; 2009 May; 8(5):1037-44. PubMed ID: 19383847
[TBL] [Abstract][Full Text] [Related]
54. Mild orotic aciduria in UMPS heterozygotes: a metabolic finding without clinical consequences.
Wortmann SB; Chen MA; Colombo R; Pontoglio A; Alhaddad B; Botto LD; Yuzyuk T; Coughlin CR; Descartes M; Grűnewald S; Maranda B; Mills PB; Pitt J; Potente C; Rodenburg R; Kluijtmans LA; Sampath S; Pai EF; Wevers RA; Tiller GE;
J Inherit Metab Dis; 2017 May; 40(3):423-431. PubMed ID: 28205048
[TBL] [Abstract][Full Text] [Related]
55. Enzymes of the de novo and salvage pathways for pyrimidine biosynthesis in normal colon, colon carcinoma, and xenografts.
Ahmed NK
Cancer; 1984 Oct; 54(7):1370-3. PubMed ID: 6088027
[TBL] [Abstract][Full Text] [Related]
56. Molecular cloning and nucleotide sequence for the complete coding region of human UMP synthase.
Suttle DP; Bugg BY; Winkler JK; Kanalas JJ
Proc Natl Acad Sci U S A; 1988 Mar; 85(6):1754-8. PubMed ID: 3279416
[TBL] [Abstract][Full Text] [Related]
57. USP22 knockdown enhanced chemosensitivity of hepatocellular carcinoma cells to 5-Fu by up-regulation of Smad4 and suppression of Akt.
Zhang J; Luo N; Tian Y; Li J; Yang X; Yin H; Xiao C; Sheng J; Li Y; Tang B; Li R
Oncotarget; 2017 Apr; 8(15):24728-24740. PubMed ID: 28445968
[TBL] [Abstract][Full Text] [Related]
58. H1, a derivative of tetrandrine, enhances the efficacy of 5-FU in Bel7402/5-FU cells via suppressing STAT3/MCL-1 and inducing PUMA.
Li F; Wang J; Wu N; Zhang H; Li Z; Wei N
Biochem Biophys Res Commun; 2019 Nov; 520(1):93-98. PubMed ID: 31582208
[TBL] [Abstract][Full Text] [Related]
59. Down-regulation of Sonic hedgehog signaling pathway activity is involved in 5-fluorouracil-induced apoptosis and motility inhibition in Hep3B cells.
Wang Q; Huang S; Yang L; Zhao L; Yin Y; Liu Z; Chen Z; Zhang H
Acta Biochim Biophys Sin (Shanghai); 2008 Sep; 40(9):819-29. PubMed ID: 18776995
[TBL] [Abstract][Full Text] [Related]
60. Nestin overexpression in hepatocellular carcinoma associates with epithelial-mesenchymal transition and chemoresistance.
Zhang Y; Zeng S; Ma J; Deng G; Qu Y; Guo C; Shen H
J Exp Clin Cancer Res; 2016 Jul; 35(1):111. PubMed ID: 27412382
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
